Imami Nesrina, Herasimtschuk Anna A
a Department of Medicine ; Imperial College London ; London , UK.
Hum Vaccin Immunother. 2015;11(9):2287-93. doi: 10.1080/21645515.2015.1021523.
Immunotherapy in the context of treated HIV-1 infection aims to improve immune responses to achieve better control of the virus. To date, multifaceted immunotherapeutic approaches have been shown to reduce immune activation and increase CD4 T-lymphocyte counts, further to the effects of antiretroviral therapy alone, in addition to improving HIV-1-specific T-cell responses. While sterilizing cure of HIV-1 would involve elimination of all replication-competent virus, a functional cure in which the host has long-lasting control of viral replication may be more feasible. In this commentary, we discuss novel strategies aimed at targeting the latent viral reservoir with cure of HIV-1 infection being the ultimate goal, an achievement that would have considerable impact on worldwide HIV-1 infection.
在已接受治疗的HIV-1感染背景下,免疫疗法旨在改善免疫反应以更好地控制病毒。迄今为止,多方面的免疫治疗方法已被证明除了能改善HIV-1特异性T细胞反应外,还能在单纯抗逆转录病毒疗法的基础上,减少免疫激活并增加CD4 T淋巴细胞计数。虽然HIV-1的清除性治愈需要消除所有具有复制能力的病毒,但宿主对病毒复制具有长期控制能力的功能性治愈可能更可行。在这篇评论中,我们讨论了以治愈HIV-1感染为最终目标的针对潜伏病毒库的新策略,这一成果将对全球HIV-1感染产生重大影响。